UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Nature medicine, 2012-11, Vol.18 (11), p.1639-1642

2012

Volltextzugriff (PDF)

Androgen Receptor in Hormone Receptor-Positive Breast Cancer

International journal of molecular sciences, 2023-12, Vol.25 (1), p.476

2023

Volltextzugriff (PDF)

Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

Cell communication and signaling, 2020-09, Vol.18 (1), p.154-154, Article 154

2020

Volltextzugriff (PDF)

Differential expression of SUMO-specific protease 7 variants regulates epithelial–mesenchymal transition

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17466-17471

2012

Volltextzugriff (PDF)

SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms

The Journal of biological chemistry, 2010-08, Vol.285 (33), p.25859-25866

2010

Volltextzugriff (PDF)

Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells

Biomolecules (Basel, Switzerland), 2023-02, Vol.13 (2), p.345

2023

Volltextzugriff (PDF)

SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability

Cell reports (Cambridge), 2016-04, Vol.15 (1), p.147-157

2016

Volltextzugriff (PDF)

Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer

Cells (Basel, Switzerland), 2023-10, Vol.12 (20), p.2495

2023

Volltextzugriff (PDF)

Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells

The Journal of biological chemistry, 2007-12, Vol.282 (52), p.37341-37349

2007

Volltextzugriff (PDF)

SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression

Genes & cancer, 2010-07, Vol.1 (7), p.748-752

2010

Volltextzugriff (PDF)

Isolation of In Vivo SUMOylated Chromatin-Bound Proteins

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1475, p.205

Bawa-Khalfe, Tasneem

2016

Volltextzugriff (PDF)

β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma

Journal of the American Society of Nephrology, 2015-03, Vol.26 (3), p.553-564

2015

Volltextzugriff (PDF)

The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling

Oncotarget, 2018-02, Vol.9 (15), p.12201-12211

2018

Volltextzugriff (PDF)

Abstract PS17-33: Sumo-modified androgen receptors support the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS17-33-PS17-33

2021

Volltextzugriff (PDF)

Abstract PD1-07: Mutant ESR1 receptors antagonize the tumor suppressor function of androgen receptors

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD1-07-PD1-07

2022

Volltextzugriff (PDF)

Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell Transformation

Scientific reports, 2017-04, Vol.7 (1), p.46477-46477, Article 46477

2017

Volltextzugriff (PDF)

Abstract PD8-09: Androgen and ESR1 mutant receptors mechanistically collaborate for overexpression of genes associated with poor outcomes in ER-positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD8-09-PD8-09

2021

Volltextzugriff (PDF)

Abstract 5683: lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5683-5683

2024

Volltextzugriff (PDF)

SENP1 regulates PTEN stability to dictate prostate cancer development

Oncotarget, 2017-03, Vol.8 (11), p.17651-17664

2017

Volltextzugriff (PDF)

Abstract A023: lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer

Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3_Supplement_1), p.A023-A023

2024

Volltextzugriff (PDF)

Abstract PO5-05-09: Testing AI-Predicted Protein Motifs that Direct Constitutive Genomic AR Activity in Endocrine Resistant Breast Cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-05-09-PO5-05-09

2024

Volltextzugriff (PDF)

Abstract LB-095: Aurora-A is elevated in cancer cells due to inactivation of EF1A2-PTEN-GSK3b regulated late S-G2 phase specific degradation pathway

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-095-LB-095

2019

Volltextzugriff (PDF)

SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model

NAR genomics and bioinformatics, 2024-03, Vol.6 (1)

2024

Volltextzugriff (PDF)

SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy

Oncotarget, 2016-05, Vol.7 (21), p.30336-30349

2016

Volltextzugriff (PDF)

Novel SUMO-Protease SENP7S Regulates [beta]-catenin Signaling and Mammary Epithelial Cell Transformation

Scientific reports, 2017-04, Vol.7, p.46477

2017

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Androgen Receptor in Hormone Receptor-Positive Breast Cancer

Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

Differential expression of SUMO-specific protease 7 variants regulates epithelial–mesenchymal transition

SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms

Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells

SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability

Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer

Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells

SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression

Isolation of In Vivo SUMOylated Chromatin-Bound Proteins

β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma

The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling

Abstract PS17-33: Sumo-modified androgen receptors support the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

Abstract PD1-07: Mutant ESR1 receptors antagonize the tumor suppressor function of androgen receptors

Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell Transformation

Abstract PD8-09: Androgen and ESR1 mutant receptors mechanistically collaborate for overexpression of genes associated with poor outcomes in ER-positive metastatic breast cancer

Abstract 5683: lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer

SENP1 regulates PTEN stability to dictate prostate cancer development

Abstract A023: lncRNA-protein interactions that predict response to endocrine therapy in HR+ breast cancer

Abstract PO5-05-09: Testing AI-Predicted Protein Motifs that Direct Constitutive Genomic AR Activity in Endocrine Resistant Breast Cancer

Abstract LB-095: Aurora-A is elevated in cancer cells due to inactivation of EF1A2-PTEN-GSK3b regulated late S-G2 phase specific degradation pathway

SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model

SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy

Novel SUMO-Protease SENP7S Regulates [beta]-catenin Signaling and Mammary Epithelial Cell Transformation

Suchergebnisse filtern